Stay updated on Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.2.0 to v3.3.2. The update appears limited to site version display and does not affect study data or functionality.
    Difference
    0.0%
    Check dated 2025-11-24T17:52:18.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Removed the government funding/status notice banner from the page, a non-core site-wide element that does not alter the study record, data, or user navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:29:12.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Record History now displays additional version entries with updated timestamps, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-03T09:57:14.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding lapse notice and confirms the NIH Clinical Center is open, with status sources listed, and a version upgrade to v3.2.0.
    Difference
    8%
    Check dated 2025-10-05T14:26:04.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T09:46:28.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2; Back to Top element removed. Core content and key data remain unchanged.
    Difference
    0.5%
    Check dated 2025-09-14T00:16:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.